$TLYS
TILLY'S, INC.

2014 Q2 Form 10-Q Financial Statement

#000119312514233153 Filed on June 11, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2013 Q2
Revenue $111.1M $109.1M
YoY Change 1.85% 13.05%
Cost Of Revenue $79.81M $77.31M
YoY Change 3.23% 16.95%
Gross Profit $31.33M $31.81M
YoY Change -1.51% 4.56%
Gross Profit Margin 28.19% 29.15%
Selling, General & Admin $30.25M $27.89M
YoY Change 8.47% 14.34%
% of Gross Profit 96.56% 87.68%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.780M $4.650M
YoY Change 2.8% 19.23%
% of Gross Profit 15.26% 14.62%
Operating Expenses $30.25M $27.89M
YoY Change 8.47% 14.34%
Operating Profit $1.077M $3.917M
YoY Change -72.5% -35.0%
Interest Expense $49.00K
YoY Change 11.36%
% of Operating Profit 1.25%
Other Income/Expense, Net $0.00 -$49.00K
YoY Change -100.0%
Pretax Income $1.077M $3.868M
YoY Change -72.16% -35.34%
Income Tax $486.0K $1.560M
% Of Pretax Income 45.13% 40.33%
Net Earnings $591.0K $2.308M
YoY Change -74.39% -60.97%
Net Earnings / Revenue 0.53% 2.12%
Basic Earnings Per Share $0.02 $0.08
Diluted Earnings Per Share $0.02 $0.08
COMMON SHARES
Basic Shares Outstanding 27.98M shares 27.69M shares
Diluted Shares Outstanding 28.15M shares 28.03M shares

Balance Sheet

Concept 2014 Q2 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $52.40M $48.60M
YoY Change 7.82% 123.96%
Cash & Equivalents $27.40M $18.62M
Short-Term Investments $25.00M $29.90M
Other Short-Term Assets $11.90M $12.40M
YoY Change -4.03% 125.45%
Inventory $52.85M $49.67M
Prepaid Expenses
Receivables $9.300M $8.100M
Other Receivables $0.00 $0.00
Total Short-Term Assets $126.5M $118.7M
YoY Change 6.55% 56.17%
LONG-TERM ASSETS
Property, Plant & Equipment $105.1M $87.32M
YoY Change 20.41% 32.91%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.715M $3.660M
YoY Change 28.83% 4.57%
Total Long-Term Assets $109.9M $90.98M
YoY Change 20.75% 31.48%
TOTAL ASSETS
Total Short-Term Assets $126.5M $118.7M
Total Long-Term Assets $109.9M $90.98M
Total Assets $236.3M $209.7M
YoY Change 12.71% 44.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $21.77M $20.17M
YoY Change 7.9% 15.27%
Accrued Expenses $11.65M $13.24M
YoY Change -12.05% -16.7%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $800.0K $700.0K
YoY Change 14.29% 0.0%
Total Short-Term Liabilities $48.35M $46.86M
YoY Change 3.18% 12.65%
LONG-TERM LIABILITIES
Long-Term Debt $2.300M $3.100M
YoY Change -25.81% -18.42%
Other Long-Term Liabilities $43.40M $39.20M
YoY Change 10.71% 16.32%
Total Long-Term Liabilities $45.74M $42.30M
YoY Change 8.14% 12.8%
TOTAL LIABILITIES
Total Short-Term Liabilities $48.35M $46.86M
Total Long-Term Liabilities $45.74M $42.30M
Total Liabilities $94.10M $89.16M
YoY Change 5.53% 12.72%
SHAREHOLDERS EQUITY
Retained Earnings $18.59M $2.168M
YoY Change 757.38%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $142.2M $120.5M
YoY Change
Total Liabilities & Shareholders Equity $236.3M $209.7M
YoY Change 12.71% 44.4%

Cashflow Statement

Concept 2014 Q2 2013 Q2
OPERATING ACTIVITIES
Net Income $591.0K $2.308M
YoY Change -74.39% -60.97%
Depreciation, Depletion And Amortization $4.780M $4.650M
YoY Change 2.8% 19.23%
Cash From Operating Activities $100.0K $2.908M
YoY Change -96.56% -26.01%
INVESTING ACTIVITIES
Capital Expenditures $7.943M $11.44M
YoY Change -30.54% 52.0%
Acquisitions
YoY Change
Other Investing Activities $10.01M $10.01M
YoY Change 0.0% 1464.06%
Cash From Investing Activities $2.070M -$1.424M
YoY Change -245.37% -79.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -190.0K -174.0K
YoY Change 9.2% -58.87%
NET CHANGE
Cash From Operating Activities 100.0K 2.908M
Cash From Investing Activities 2.070M -1.424M
Cash From Financing Activities -190.0K -174.0K
Net Change In Cash 1.980M 1.310M
YoY Change 51.15% -138.81%
FREE CASH FLOW
Cash From Operating Activities $100.0K $2.908M
Capital Expenditures $7.943M $11.44M
Free Cash Flow -$7.843M -$8.527M
YoY Change -8.02% 137.32%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
13.31
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2356790 shares
CY2014Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
17997000
CY2014Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
6214000
CY2014Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2014Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9241000
CY2014Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4975000
CY2014Q1 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
758000
CY2014Q1 us-gaap Liabilities
Liabilities
91484000
CY2014Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
45256000
CY2014Q1 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
42756000
CY2014Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
122886000
CY2014Q1 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
5395000
CY2014Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
19645000
CY2014Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
25000000
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18624000
CY2014Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1255790 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.99
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3094290 shares
CY2014Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q2 us-gaap Number Of Stores
NumberOfStores
198 Store
CY2014Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
12.93
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
12.13
CY2014Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
232407000
CY2014Q1 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
2500000
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2848108 shares
CY2014Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
48353000
CY2014Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
12000
CY2014Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3458000
CY2014Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
123598000
CY2014Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
21766000
CY2014Q2 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
2303000
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
142226000
CY2014Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
18588000
CY2014Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
5202000
CY2014Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2014Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11648000
CY2014Q2 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
770000
CY2014Q2 us-gaap Liabilities
Liabilities
94096000
CY2014Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
45743000
CY2014Q2 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
43440000
CY2014Q2 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
5509000
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
236322000
CY2014Q2 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
0
CY2014Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4715000
CY2014Q2 us-gaap Inventory Net
InventoryNet
52850000
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
105146000
CY2014Q2 us-gaap Assets
Assets
236322000
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
1889000
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27396000
CY2014Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1884000
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1890000
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
140923000
CY2014Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
8800000
CY2014Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11948000
CY2014Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
9296000
CY2014Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
24971000
CY2014Q2 us-gaap Assets Current
AssetsCurrent
126461000
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17314000
CY2014Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q1 us-gaap Number Of Stores
NumberOfStores
195 Store
CY2014Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2014Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q1 us-gaap Liabilities Current
LiabilitiesCurrent
46228000
CY2014Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
12000
CY2013Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
31000
CY2013Q2 us-gaap Interest Paid
InterestPaid
67000
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3868000
CY2014Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4533000
CY2014Q1 us-gaap Inventory Net
InventoryNet
46266000
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
100936000
CY2014Q1 us-gaap Assets
Assets
232407000
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25412000
CY2014Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11772000
CY2014Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
8545000
CY2014Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
34943000
CY2014Q1 us-gaap Assets Current
AssetsCurrent
126938000
CY2014Q1 us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2017-05-31
CY2014Q1 us-gaap Line Of Credit Facility Initiation Date1
LineOfCreditFacilityInitiationDate1
2014-03-17
CY2014Q1 tlys Line Of Credit Facility Unused Capacity Commitment Fee Percentage Eliminated
LineOfCreditFacilityUnusedCapacityCommitmentFeePercentageEliminated
0.0010 pure
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28027000 shares
CY2013Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
335000 shares
CY2013Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
2908000
CY2013Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.403 pure
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27692000 shares
CY2013Q2 us-gaap Sales Revenue Net
SalesRevenueNet
109119000
CY2013Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11435000
CY2013Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
786000
CY2013Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2494000
CY2013Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-49000
CY2013Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1648000
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2339000
CY2013Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
44000
CY2013Q2 us-gaap Gross Profit
GrossProfit
31806000
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
3917000
CY2013Q2 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
3000
CY2013Q2 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
2155000
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
2308000
CY2013Q2 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
174000
CY2013Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3070000
CY2013Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
31000
CY2013Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
77313000
CY2013Q2 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-174000
CY2013Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
347000
CY2013Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-2728000
CY2013Q2 us-gaap Share Based Compensation
ShareBasedCompensation
892000
CY2013Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4650000
CY2013Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1310000
CY2013Q2 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1424000
CY2013Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
27889000
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1560000
CY2013Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-928000
CY2013Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1493000
CY2013Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1912000
CY2013Q2 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
11000
CY2013Q2 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
10000000
CY2013Q2 tlys Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
1882000
CY2014Q2 dei Trading Symbol
TradingSymbol
TLYS
CY2014Q2 dei Entity Registrant Name
EntityRegistrantName
TILLY'S, INC.
CY2014Q2 dei Amendment Flag
AmendmentFlag
false
CY2014Q2 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2014Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014Q2 dei Document Type
DocumentType
10-Q
CY2014Q2 dei Document Period End Date
DocumentPeriodEndDate
2014-05-03
CY2014Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001524025
CY2014Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
CY2014Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2014Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
15.57
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2014Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y9M18D
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
812500 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.018 pure
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28151000 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.469 pure
CY2014Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
168000 shares
CY2014Q2 us-gaap Line Of Credit Facility Covenant Compliance
LineOfCreditFacilityCovenantCompliance
The Company was in compliance with all of its covenants and had no outstanding borrowings under the line of credit.
CY2014Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
103000
CY2014Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.405 pure
CY2014Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
12.31
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2014Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2014Q2 us-gaap Debt Instrument Covenant Description
DebtInstrumentCovenantDescription
The Company is required to maintain certain financial and nonfinancial covenants in accordance with the revolving credit facility. The financial covenants require certain levels of leverage and profitability, such as (i) an aggregate maximum net loss after taxes not to exceed $5 million (measured at the end of each fiscal quarter), with no more than one annual net loss after taxes for any fiscal year (in either case, excluding all charges for impairment of goodwill, other intangibles and store assets impairment on the balance sheet of WOJT, in an aggregate amount of up to $2.0 million for the relevant period), and (ii) a maximum ratio of 2.00 to 1.00 for “balance sheet leverage”, defined as total liabilities divided by total tangible net worth.
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
75000 shares
CY2014Q2 us-gaap Debt Instrument Interest Rate Terms
DebtInstrumentInterestRateTerms
The interest charged on borrowings is either at the London Interbank Offered Rate, or LIBOR, plus 1.00%, or at the bank's prime rate. The Company has the ability to select between the prime rate or LIBOR-based rate at the time of a cash advance.
CY2014Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2014Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27983000 shares
CY2014Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y10M24D
CY2014Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
591000
CY2014Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
37000
CY2014Q2 us-gaap Gross Profit
GrossProfit
31327000
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1077000
CY2014Q2 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-29000
CY2014Q2 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
751000
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
591000
CY2014Q2 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
185000
CY2014Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P7Y8M12D
CY2014Q2 us-gaap Sales Revenue Net
SalesRevenueNet
111134000
CY2014Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7943000
CY2014Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
-22000
CY2014Q2 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
4991000
CY2014Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3422000
CY2014Q2 us-gaap Interest Paid
InterestPaid
50000
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1077000
CY2014Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
517000
CY2014Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6584000
CY2014Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
838000
CY2014Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
79807000
CY2014Q2 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-185000
CY2014Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
34000
CY2014Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1517000
CY2014Q2 us-gaap Share Based Compensation
ShareBasedCompensation
838000
CY2014Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4776000
CY2014Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1984000
CY2014Q2 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
2066000
CY2014Q2 us-gaap Adjustments To Additional Paid In Capital Income Tax Deficiency From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalIncomeTaxDeficiencyFromShareBasedCompensation
126000
CY2014Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
30250000
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
486000
CY2014Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1012000
CY2014Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1279000
CY2014Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2176000
CY2014Q2 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
15000000
CY2014Q2 tlys Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
798000

Files In Submission

Name View Source Status
0001193125-14-233153-index-headers.html Edgar Link pending
0001193125-14-233153-index.html Edgar Link pending
0001193125-14-233153.txt Edgar Link pending
0001193125-14-233153-xbrl.zip Edgar Link pending
d711499d10q.htm Edgar Link pending
d711499dex311.htm Edgar Link pending
d711499dex312.htm Edgar Link pending
d711499dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tlys-20140503.xml Edgar Link completed
tlys-20140503.xsd Edgar Link pending
tlys-20140503_cal.xml Edgar Link unprocessable
tlys-20140503_def.xml Edgar Link unprocessable
tlys-20140503_lab.xml Edgar Link unprocessable
tlys-20140503_pre.xml Edgar Link unprocessable